![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 30, 22806-22814, July 28, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Cell Biology, Box 3709, Duke University
Medical Center, Durham, North Carolina 27710
Received for publication, February 22, 2000, and in revised form, May 8, 2000
The N-terminal domain of eukaryotic Hsp90
proteins contains a conserved adenosine nucleotide binding pocket that
also serves as the binding site for the Hsp90 inhibitors geldanamycin
and radicicol. Although this domain is essential for Hsp90 function, the molecular basis for adenosine nucleotide-dependent
regulation of GRP94, the endoplasmic reticulum paralog of Hsp90,
remains to be established. We report that bis-ANS
(1,1'-bis(4-anilino-5-napthalenesulfonic acid), an environment
sensitive fluorophore known to interact with nucleotide-binding
domains, binds to the adenosine nucleotide-binding domain of GRP94 and
thereby activates its molecular chaperone and peptide binding
activities. bis-ANS was observed to elicit a tertiary conformational
change in GRP94 similar to that occurring upon heat shock, which also
activates GRP94 function. bis-ANS activation of GRP94 function was
efficiently blocked by radicicol, an established inhibitory ligand for
the adenosine nucleotide binding pocket. Confirmation of the N-terminal
nucleotide binding pocket as the bis-ANS-binding site was obtained
following covalent incorporation of bis-ANS into GRP94, trypsinolysis,
and sequencing of bis-ANS-labeled limit digestion products. These data
identify a ligand dependent regulation of GRP94 function and suggest a model whereby GRP94 function is regulated through a
ligand-dependent conversion of GRP94 from an inactive to an
active conformation.
GRP94,1 the endoplasmic
reticulum paralog of cytosolic Hsp90, is an abundant resident
endoplasmic reticulum lumenal protein that by virtue of its association
with nascent polypeptides is thought to perform a chaperone function
(1-6). Consistent with this role, GRP94 expression is up-regulated by
stress conditions that promote protein misfolding or unfolding, such as
glucose starvation and heat shock (7-9). In addition to its role in
the regulation of protein folding in the endoplasmic reticulum, GRP94 can function in the intercellular trafficking of peptides from the
extracellular space to the major histocompatability complex class I
antigen processing pathway of professional antigen presenting cells
(10-13). The observation that GRP94 can function as a peptide-binding protein derives from the pioneering studies of Srivastava and colleagues (14) identifying GRP94 (gp96) as a tumor rejection antigen
(14). Subsequent studies have demonstrated that GRP94-peptide complexes
can elicit major histocompatability complex class I restricted immune
responses against a wide variety of peptide epitopes (11, 15-18).
Thus, in addition to a homeostatic role in protein folding and
assembly, GRP94 appears to function, in an as yet undefined manner, as
a component of the major histocompatability complex class I antigen
processing and presentation pathways of mammalian cells.
The mechanism and regulation of GRP94 interactions with peptide and
polypeptide substrates remains unknown. Experiments conducted with
purified GRP94 and synthetic peptides have demonstrated that GRP94
binds peptides in vitro and that this peptide binding
activity is markedly stimulated by heat shock (15, 19-22). The
conformational and regulatory consequences of heat shock on GRP94
activity have, however, only begun to be studied. It is clear from
recent data that the stimulation of peptide binding that accompanies
heat shock occurs in the context of a tertiary conformational change and is accompanied by exposure of a hydrophobic domain(s) accessible to
the environment sensitive fluorophore Nile Red (21).
The recent identification of a conserved adenosine nucleotide binding
pocket in the N-terminal domain of eukaryotic Hsp90 proteins has
focused recent investigations into the role of adenosine nucleotides in
the regulation of Hsp90 and GRP94 function (23-26). It has been
established that ATP is necessary for stable association of Hsp90 with
the accessory factor p23 (25, 27, 28), although the identification of
adenosine nucleotide-dependent regulation of
Hsp90-substrate interactions has proven difficult (28, 29). Perhaps
indicative of the complexity of Hsp90-adenosine nucleotide interactions, the recombinant N-terminal adenosine nucleotide-binding domain displays enzymatic activities that differ substantially from the
native protein (24, 25). With respect to GRP94, evidence in support of
intrinsic ATP binding and ATPase activities is controversial and a
consensus regarding the molecular basis of an adenosine nucleotide-mediated regulation of GRP94-substrate interactions has yet
to emerge (20, 26, 30-32).
To further investigate the structural basis for the activation of GRP94
peptide binding activity that accompanies heat shock, we examined the
interaction of GRP94 with the environment-sensitive fluorophores,
Prodan, 8-ANS, and bis-ANS. Because of its unique characteristics, we
focused attention on bis-ANS. Bis-ANS has been used as a probe of the
conformational state of a wide range of proteins including the
molecular chaperones GroEL and DnaK (33, 34). bis-ANS is known to bind
to hydrophobic sites on proteins and, unlike Prodan and 8-ANS, bis-ANS
also interacts with nucleotide-binding sites (35-37). In this study we
report that bis-ANS elicits a conformational change in GRP94 that is accompanied by a substantial increase in chaperone and peptide binding
activity. The activation of GRP94 function by bis-ANS is blocked by
radicicol, an established ligand for the conserved, N-terminal
nucleotide binding pocket of the eukaryotic Hsp90s (38, 39). On the
basis of these data, we propose a model in which ligand binding to the
N-terminal nucleotide-binding domain of GRP94 elicits a conformational
change that converts GRP94 from an inactive to an active conformation,
wherein the chaperone and peptide binding activities of GRP94 are
markedly stimulated.
Materials--
Fluorescent probes were obtained from Molecular
Probes (Eugene, OR). bis-ANS concentration was determined by absorbance
at 385 nm ( Fluorophore Binding Reactions--
All binding reactions, with
the exception of the indicated circular dichroism and citrate synthase
aggregation experiments, were conducted in buffer A (110 mM
KOAc, 20 mM NaCl, 2 mM Mg(OAc)2, 25 mM K-HEPES, pH 7.2, 100 µM
CaCl2). Fluorescent probe and radicicol stocks were
prepared in dimethyl formamide at 5 mM final concentration. For all assays, control reactions at solvent dilutions identical to
experimental conditions were performed to correct for any solvent effects. Where indicated, GRP94 was heat shocked by incubation in a
50 °C water bath for 15 min followed by cooling to 37 °C.
Fluorescence Measurements--
Emission spectra were obtained in
a FluorMax spectrofluorometer (SPEX Industries Inc., Edison, NJ)
operating in photon counting mode. Spectra were recorded and processed
with DM3000f operating software, version 2.1 (SPEX Industries Inc.,
Edison, NJ). For emission scans, slit width was set at 1 nm. Excitation
wavelengths were as follows: Prodan, 360 nm; ANS, 372 nm; bis-ANS, 393 nm; tryptophan, 295 nm. All spectra were background corrected.
Circular Dichroism Measurements--
Far-UV CD spectrometry was
performed on an AVIV Associates 62DS circular dichroism spectrometer
(AVIV Associates, Lakewood, NJ). Samples were analyzed in a 1-mm path
length quartz cuvette at 37 °C. GRP94 samples (1 µM)
were prepared in standard phosphate-buffered saline solution as buffer
A produced unacceptable dynode voltages in the relevant region of the
spectrum. GRP94 was incubated with 10 µM bis-ANS for
2 h at 37 °C prior to obtaining spectra. Spectra were recorded
from 300 to 195 nm. The Conformational Analysis by Proteolysis--
The conformational
state of GRP94 was assessed by tryptic digestion of the protein and
subsequent SDS-PAGE analysis. For simple proteolysis experiments, 10 µl of a 0.5 mg/ml GRP94 stock, with or without prior heat shock, was
combined with 1 µl of bis-ANS and/or radicicol stock solutions and
incubated for the indicated times at 37 °C. Samples were then
combined with 0.1% trypsin and digested for 30 min at 37 °C. An
equal volume of SDS-PAGE sample buffer was added and the samples were
snap frozen in liquid nitrogen. Immediately prior to gel analysis,
samples were thawed and boiled for 5 min. Samples were then separated
on 12.5% SDS-polyacrylamide gels. Gels were fixed and stained with
Coomassie Blue. For time course experiments, excess free bis-ANS was
removed immediately prior to trypsinization by gel filtration on 0.5-ml
G-25 Sephadex spin columns.
Identification of the bis-ANS-binding Site--
The
bis-ANS-binding region of GRP94 was identified by covalent
incorporation of bis-ANS into GRP94 following the bis-ANS photolysis procedures described in Refs. 42 and 43. Briefly, 50 µg of GRP94 was
combined with 50 µM bis-ANS in a final volume of 100 µl
and photocross-linked for 15 min on ice with a 366-nm hand-held UV lamp
(Ultra-violet Products, Inc., San Gabriel, CA). Following photocross-linking, GRP94-bis-ANS complexes were digested with trypsin
for 1 h at 37 °C. The trypsin-derived limit digestion products
were then separated by C-18 reverse phase high performance liquid
chromatography using a continuous acetonitrile/water gradient in 20 mM ammonium bicarbonate, with sequential detection by UV absorbance (220 nm) and fluorescence emission (excitation 418 nm;
emission 498 nm). The major resultant fluorescent peak was collected
and the corresponding peptide sequenced by Edman degradation on an
Applied Biosystems Procise model 492 automated protein sequencer.
Native Blue Electrophoresis--
The oligomeric state of GRP94
was assayed by blue native-PAGE as described previously (44). GRP94 was
either heat shocked or exposed to a 10-fold molar excess of bis-ANS for
the indicated times. Samples were then dissolved in 15% glycerol and
loaded onto 5-18% gradient gels with 0.02% Coomassie Brilliant Blue
in the cathode buffer. Gels were run at 4 °C, stained with Coomassie Blue, destained, and dried.
Citrate Synthase Aggregation Assays--
The effects of GRP94 on
the thermal aggregation of citrate synthase were assayed by the methods
of Buchner and colleagues (45). Samples containing no protein, or GRP94
(1 µM), were incubated in 40 mM HEPES, pH
7.5, for 2 h at 37 °C with either 0.2%
N,N-dimethylformamide or 10 µM bis-ANS. The
samples were then warmed to 43 °C for 5 min and placed in a
spectrofluorometer thermostatted at 43 °C. Citrate synthase was then
added to 0.15 µM final concentration and the thermal
aggregation of the enzyme followed by light scattering. Excitation and
emission wavelengths were both 500 nm with 2 nm slit width. The time
course of citrate synthase aggregation was followed for 1000 s.
Peptide Binding to GRP94--
Iodination of VSV8 was performed
by the Iodo-Beads procedure (Pierce Chemical Co.), and unincorporated
125I was removed by fractionation on a Sep-Pak C18
reverse-phase cartridge. Iodinated peptide was mixed with unlabeled
peptide to yield a final specific activity of 6.0 µCi/mg. GRP94 (4.7 µg, final concentration 0.5 µM) was incubated with an
equimolar quantity of bis-ANS in 0.1% N,N-dimethylformamide
in 100 µl of buffer A for 3.5 h at 37 °C. Samples were then
incubated for an additional 30 min at 37 °C, or heat shocked for 15 min at 50 °C and allowed to recover for 15 min at 37 °C. A
10-fold molar excess of 125I-VSV8 was added (final
concentration, 5 µM) and the mixture incubated for 30 min
at 37 °C. All incubations were performed in the dark to prevent
bis-ANS degradation. Samples were then eluted on 1.2-ml Sephadex G-75
spin columns preblocked with 75 µg of bovine serum albumin, and
125I was quantitated by Binding of Polarity-sensitive Fluorescent Probes to
GRP94--
Recent studies on the conformational regulation of GRP94
have identified a tertiary structural change that occurs in response to
heat shock and is associated with an activation of peptide binding
activity (21, 22). Coincident with the heat shock-elicited conformational change, GRP94 displays enhanced binding of environment sensitive fluorescent probes such as Nile Red, which preferentially bind to hydrophobic domains (21). GRP94 contains two domains of
significant hydrophobicity, a C-terminal assembly domain and a highly
conserved N-terminal region, which corresponds to the Hsp90
geldanamycin and adenosine nucleotide-binding site (24, 46). To
characterize the structural basis for the heat
shock-dependent activation of GRP94 activity, the
interaction of polarity-sensitive fluorophores with native and
heat-shocked GRP94 was examined. The three probes tested, Prodan
(6-propionyl-2-(dimethylamino)naphthalene), 8-ANS, and bis-ANS are
structurally related probes which bind to hydrophobic sites on proteins
and undergo substantial fluorescence spectrum changes upon introduction
into nonpolar environments (34-36, 47). The following experimental
protocol was utilized. GRP94 was warmed to 37 °C and either
maintained at 37 °C or heat shocked for 15 min at 50 °C, followed
by incubation at 37 °C. Subsequently, probe was added to the GRP94
solution and emission spectra recorded after 30 min at 37 °C. As
depicted in Fig. 1A, the
emission maxima of Prodan in the presence of native or heat-shocked GRP94 were essentially identical, indicating that Prodan does not
interact with the hydrophobic binding pocket(s) displayed by
heat-shocked GRP94. In contrast, the structurally related probe, 8-ANS,
displays weak interactions with native GRP94, yet binds avidly
following heat shock (Fig. 1B). At present, it is not known if 8-ANS binding to native GRP94 represents the binding of 8-ANS to a
weakly hydrophobic site present on the entire population of molecules
or whether 8-ANS binds to a strongly hydrophobic site present on a
small fraction of native GRP94 molecules, but uniformly represented on
the heat shocked population of GRP94.
The interaction of bis-ANS with GRP94 was complex, and displayed clear
time and concentration dependence. As depicted in Fig. 1, C
and D, the initial bis-ANS binding to native GRP94 was
biphasic and following extended incubations in the presence of bis-ANS, a level of fluorophore binding similar to that seen with heat-shocked GRP94 was observed. Maximal bis-ANS binding to heat-shocked GRP94 occurred very rapidly and under the described experimental setting, could not be time resolved. At 10-fold higher probe and protein concentrations (as used in later experiments) bis-ANS binding to native
GRP94 was much more rapid, with 85% maximal binding occurring in
1 h (data not shown). These data suggest that maximal bis-ANS
binding to GRP94 required a slow structural transition. This transition
may represent a bis-ANS elicited conformational change in GRP94 and/or
the bis-ANS dependent stabilization of a distinct conformational state
accessed by the native protein.
Analysis of bis-ANS Binding to Heat-shocked GRP94--
To
determine the affinity of bis-ANS for GRP94, bis-ANS was added to
increasing concentrations of heat-shocked GRP94, the fluorescence
spectrum was determined, and the emission intensity at 475 nm plotted
as a function of GRP94 concentration (Fig.
2, A and B). Under
the described experimental conditions, bis-ANS binding to GRP94 was
near-maximal at a 20-fold molar excess of GRP94 monomer over bis-ANS.
From the Klotz plot (59, 60), a Kd of 110 nM for GRP94-bis-ANS interactions was determined. In this
experimental format, where the ligand concentration is constant and the
receptor concentration is varied, the Kd value more
accurately indicates the concentration of unbound receptor (GRP94) at
which the ligand (bis-ANS) is 50% saturated (Fig. 2B). From
a mathematical standpoint, however, the determined
Kd value is identical to that viewed from a more
traditional perspective, where the Kd represents
that concentration of ligand at which the receptor is 50% occupied.
Importantly, these data indicate that bis-ANS binds in a saturable
manner to heat-shocked GRP94.
As mentioned previously, bis-ANS serves both as a probe of GRP94
conformation, in that it preferentially binds to the conformation accessed by GRP94 during heat shock, and as a ligand to elicit such a
conformational change. Regarding the former, additional experiments
were performed to further characterize the temperature dependence of
the heat shock-elicited conformational change. Fig. 2C
depicts an experiment in which GRP94 (50 µg/ml) was incubated for
15 h at temperatures ranging from 4 to 50 °C, and the relative efficiency of conversion to the heat shock conformation determined following addition of 5 µM bis-ANS. As depicted in Fig.
2C, a small but reproducible increase in the GRP94 fraction
present in the heat shock conformation was observed following extended incubation at 37 °C (as compared with paired incubation at 4 °C). Under the described experimental conditions, the
temperature-dependent structural transition is half-maximal
at 42 °C, and maximal at 45 °C (Fig. 2C). Because
swine, the source organism for the GRP94 used in this study, commonly
achieve febrile body temperatures of 41-42 °C during periods of
bacterial or viral
infection,2 the
conformational change identified in these studies may represent a
physiologically relevant mechanism for regulating GRP94 activity.
Structural Consequences of bis-ANS Binding to GRP94--
Following
an extended incubation period, the emission spectra of bis-ANS bound to
native GRP94 bears substantial similarity to that emission spectra of
bis-ANS bound to heat shocked GRP94 (Fig. 1C). Because heat
shock is known to elicit a stable tertiary conformational change in
GRP94 (21) these data suggest that the binding of bis-ANS to GRP94
induces, or stabilizes, a conformational change similar to that
occurring in response to heat shock. To determine whether the GRP94
conformation seen upon addition of bis-ANS is similar to that observed
following heat shock, a series of structural studies on the
bis-ANS·GRP94 complex was performed. In one series of
experiments, the proteolysis patterns of native, heat-shocked, and
bis-ANS-treated GRP94 were examined. As shown in Fig.
3A, lanes 2 and 3,
incubation of native GRP94 with low levels of trypsin yields two
prominent proteolysis products, representing known structural domains
of the protein (24, 46, 48). In contrast, proteolysis of either
bis-ANS-treated or heat-shocked GRP94 yields a substantially reduced
recovery of these prominent proteolysis products, with the concomitant
appearance of a diverse array of proteolytic fragments of higher
SDS-PAGE mobility. Essentially identical proteolysis patterns were
observed following either heat shock or bis-ANS treatment of Hsp90
(data not shown). These data provide evidence that bis-ANS binding to
GRP94 elicits or stabilizes GRP94 in a conformation similar to that
occurring in response to heat shock, suggesting that there exists a
GRP94 conformational state that can be readily accessed and/or
stabilized by either heat shock or ligand (bis-ANS) binding.
Effects of bis-ANS Binding on GRP94 Quaternary and Secondary
Structure--
When purified from tissue, GRP94 exists as a homodimer
(40, 49). Following heat shock, however, GRP94 forms higher molecular weight complexes (21). To further characterize the effects of bis-ANS
on GRP94 quaternary structure, the oligomerization states of native,
heat-shocked, and bis-ANS-treated GRP94 were assayed by the blue
native-PAGE technique (44). In these experiments, GRP94 was incubated
with bis-ANS or briefly heat shocked and subsequently incubated at
37 °C. The samples were then analyzed by gradient blue native-gel
electrophoresis (44). In this procedure, nondenaturing Coomassie dye
binds to the protein and acts as the dominant charge carrying moiety,
thus allowing assignment of molecular weights with an accuracy
comparable to that of SDS-PAGE (44). As is apparent in Fig.
4, in the absence of heat shock or
bis-ANS treatment the majority of GRP94 exists as a dimer with an
apparent molecular mass of approximately 200 kDa. However,
exposure to heat shock causes a relatively rapid formation of
tetramers, hexamers, and octamers (Fig. 4, lanes 2-4).
Incubation of GRP94 with a 10-fold molar excess of bis-ANS induces
changes in the quaternary structure of GRP94 that mimic those seen upon
heat shock (Fig. 4, lanes 4 and 5). These data
lend further support to the hypothesis that bis-ANS induces or
stabilizes a structural transition in GRP94 that is similar to that
occurring in response to heat shock.
To gain additional insights into the GRP94 conformational occurring in
response to bis-ANS treatment, native and bis-ANS-treated GRP94 were
analyzed by circular dichroism (CD) spectroscopy. By providing a
structure-averaged estimate of Radicicol Inhibits Temperature and bis-ANS-induced GRP94
Conformational Changes--
Radicicol, a macrocyclic antibiotic, binds
to the highly conserved N-terminal nucleotide binding pocket of Hsp90
and thereby blocks Hsp90 function (38, 50). To determine if radicicol binding also influenced the structural dynamics of GRP94, the following
experiments were performed. GRP94 was incubated with increasing
concentrations of radicicol, subsequently heat-shocked, cooled, and
digested with trypsin. SDS-PAGE analysis of GRP94 treated in this
fashion demonstrated that radicicol inhibited the heat shock-induced
structural transition, as assayed by the similarities in proteolysis
patterns between native GRP94 and radicicol-treated, heat-shocked GRP94
(data not shown). Similar inhibition of the heat shock-induced
structural transition of HSP90 by radicicol was also observed (data not
shown). To determine if radicicol could also inhibit the
bis-ANS-dependent GRP94 structural transition, GRP94 was
incubated with increasing concentrations of radicicol, bis-ANS was then
added, and the samples were incubated for 1 h. Samples were
subsequently digested with trypsin and the proteolysis patterns
determined by SDS-PAGE. As is depicted in Fig.
6A, radicicol, when present at
a 10-fold molar excess over bis-ANS, efficiently blocked the
bis-ANS-dependent GRP94 conformation change.
Although the experiment depicted in Fig. 6A indicated that
radicicol was able to inhibit the appearance of the
bis-ANS-dependent conformational state, it was necessary to
determine if bis-ANS binding to GRP94 was blocked by radicicol
treatment. To this end, the following experiment was performed. GRP94
was incubated in the presence of increasing concentrations of
radicicol, subsequently heat treated under conditions sufficient to
elicit efficient bis-ANS binding, and bis-ANS binding assayed. As shown
in Fig. 6B, radicicol, in a dose-dependent
manner, inhibited bis-ANS binding to heat-treated GRP94. Because
radicicol itself blocks the heat shock-induced conformation change,
these data present two models of bis-ANS action. In one model, bis-ANS
binds to the nucleotide-binding domain and directly elicits the
observed conformational change. Radicicol, by binding to the adenosine
nucleotide binding pocket, would then be predicted to inhibit the
bis-ANS-dependent conformational change. In an alternative
model, GRP94 interconverts, in a temperature-sensitive manner, between
two conformational states, arbitrarily referred to as the open or the
closed state. In the open state, bis-ANS would bind and thereby
stabilize the open conformation whereas radicicol binding would
stabilize the closed conformation. For both models, bis-ANS binding to
the N-terminal adenosine nucleotide-binding domain was predicted and
was subsequently examined.
bis-ANS Binds to the N-terminal Adenosine
Nucleotide/Radicicol/Geldanamycin-binding Domain--
Having
determined that bis-ANS can alter the conformation of GRP94, we wished
to identify the site of bis-ANS binding to GRP94. As demonstrated
previously, irradiation of bis-ANS with UV light allows the covalent
incorporation of the probe into protein-binding sites (42, 43). As
described under "Experimental Procedures." GRP94 was combined with
an excess of bis-ANS and photocross-linked on ice for 15 min. GRP94 was
subsequently digested with trypsin, the fluorescent peptides purified
by high performance liquid chromatography, and the sequence of the
labeled peptides determined by Edman sequencing. The major resultant
fluorescent peptide yielded the sequence YSQFINFPIYV, which mapped to
residues 271-281 of the N-terminal domain of GRP94. This segment is
homologous to the human HSP90 sequence HSQFIGYPITLFV from amino acids
210 to 222, and overlaps with the C-terminal region of the adenosine
nucleotide/geldanamycin/radicicol-binding domain (24, 46).
bis-ANS Activates GRP94 Chaperone Activity--
To determine if
the bis-ANS-dependent conformational changes in GRP94 were
of functional significance, the molecular chaperone activities of
native, heat-shocked, and bis-ANS-treated GRP94 were evaluated in a
thermal aggregation assay (29, 45). In these experiments, citrate
synthase aggregation was assayed in the presence of buffer, native
GRP94, heat-shocked GRP94, or GRP94 that had been previously exposed to
bis-ANS for 2 h. Following experimental treatment of the GRP94,
reactions were equilibrated at 43 °C, citrate synthase then added
and aggregation, as represented by light scattering, was measured. In
the absence of GRP94, citrate synthase undergoes rapid thermal
aggregation and under the experimental conditions depicted in Fig.
7A, reaches a plateau level
within 15 min. In the presence of native GRP94, the degree of
aggregation is reduced, suggesting that at least a fraction of the
population of native GRP94 molecules are in an active conformation.
Under these experimental conditions, approximately 50% of the citrate synthase aggregated. At the concentration of GRP94 used in these experiments, and assuming a stoichiometric interaction, these results
indicate that roughly 8% of the native GRP94 is in the active
conformation. In the presence of heat-shocked or bis-ANS-treated GRP94,
no thermal aggregation of citrate synthase was detectable (Fig.
7A). These data indicate that the ability of GRP94 to bind to substrate proteins is greatly enhanced by prior heat shock or
bis-ANS treatment and suggest that the GRP94 conformation elicited by
heat shock or bis-ANS binding represents an active state of the
molecule.
bis-ANS Activates Peptide Binding Activity to GRP94--
To assess
the effects of bis-ANS treatment on the peptide binding activity of
GRP94, GRP94 was either treated with bis-ANS, or briefly heat shocked.
A 10-fold molar excess of 125I-VSV8 was then added
and the mixture incubated for 30 min at 37 °C. Free peptide was
separated from bound peptide by Sephadex G-75 spin column
chromatography and the bound peptide was quantitated by In this article, we present evidence demonstrating that bis-ANS
binds to the conserved, N-terminal adenosine nucleotide-binding domain
of GRP94 and elicits a tertiary conformational change yielding markedly
enhanced molecular chaperone and peptide binding activities. The
binding of bis-ANS to GRP94 is biphasic, with an initial rapid binding
phase followed by a slow, extended binding phase. In accord with these
data, we hypothesize that bis-ANS binds to and stabilizes a low
abundance GRP94 conformation, referred to as the open state. In this
model, GRP94 molecular chaperone and peptide binding activity is
intimately coupled to such a conformation change. In the absence of
regulatory ligands, access to this conformation is proposed to occur in
a time and temperature-dependent manner through intrinsic structural fluctuations. Inhibitory ligands, such as geldanamycin and
radicicol, are proposed to function by binding to and stabilizing GRP94
in a closed, or inactive, conformation (46).
The molecular basis for the regulation of GRP94 function is currently
under investigation. By analogy to its cytosolic paralog, Hsp90,
current views favor regulation of GRP94 activity through cycles of ATP
binding and hydrolysis (24, 25, 51, 52). Arguments favoring an
adenosine nucleotide-based regulatory mechanism for the Hsp90 family of
chaperones extends from crystallographic data demonstrating that the
conserved N-terminal structural domain of the Hsp90 family of
chaperones contains an ATP/ADP-binding site (24, 25). Furthermore, the
amino acid residues that function in adenosine nucleotide binding and
ATP hydrolysis, as identified by analysis of crystallographic data,
have been demonstrated to be essential in yeast (25, 52). Although the
structural and molecular genetic data implicating ATP and ADP in the
regulation of Hsp90 function are robust, biochemical analyses of ATP
and ADP effects on Hsp90 activity in vitro have not
identified the expected mode of regulation. For example, recent studies
of Hsp90 domain function using an insulin B-chain aggregation assay,
indicated that ATP, in a manner similar to the inhibitory ligand
geldanamycin, inhibited the chaperone activity of the Hsp90 N-terminal
domain (51). Thus, although ATP and ADP can be demonstrated to bind to
and influence Hsp90 conformation (27, 28, 53), it is not yet clear how
cyclic ATP binding and hydrolysis are mechanistically coupled to a
cycle of interaction between Hsp90 and unfolded polypeptide substrates.
Consistent throughout studies of the molecular regulation of Hsp90
function has been a strong correlation between conformational state and
activity. For example, heat shock has been demonstrated to elicit a
conformational change accompanied by the activation of molecular
chaperone activity (54) (current paper), peptide binding activity (19,
20), and oligomerization state (21, 55). Interestingly, the heat shock
sensitive increase in Hsp90 oligomerization state can be blocked by ATP
and geldanamycin (55), again suggesting that ATP and geldanamycin
influence Hsp90 conformation in a similar, if not identical manner. Are
such conformational changes relevant to Hsp90 or GRP94 function? In the
following, we provide a rationale for the physiological significance of
such conformational changes and argue for a ligand-mediated regulation of GRP94 conformation.
In previous studies, it was observed that native GRP94, as purified
from tissue, was present in two conformational states. These
conformational states could be distinguished by the
environment-sensitive fluorophore Nile Red and can be referred to as
the open (Nile Red accessible) and closed (Nile Red inaccessible)
conformations (21). The majority of native GRP94 is found in the closed
conformation, although the fraction present in the open conformation
can be rapidly and dramatically increased by heat shock. Thus, in a
minimal model GRP94 exists in two conformational states, with the
interconversion between the two states reflecting the structural
micro-unfolding fluctuations that are characteristic of protein
structural dynamics in their native thermal environments (56-58). That
the interconversion between the two conformational states could be
regulated by ligand binding to the N-terminal adenosine
nucleotide-binding domain is suggested by the following observations.
One, heat shock elicits a conformational change in Hsp90 and GRP94 that
is accompanied by enhanced molecular chaperone activity (54) (current
report). Two, geldanamycin and ATP block the acquisition of the heat
shock-dependent conformation (55), and three, in the
present study, it was observed that bis-ANS binds to the N-terminal
adenosine nucleotide-binding domain of GRP94 and elicits a
conformational change accompanied by enhanced molecular chaperone and
peptide binding activities. These observations highlight the importance
of the conformational state of GRP94 in the regulation of its molecular
chaperone and peptide binding activities and demonstrate that ligand
binding to the conserved, N-terminal adenosine nucleotide-binding
domain can regulate the conformation and activity state of GRP94.
Previous studies on bis-ANS binding to the Hsp70 chaperone, DnaK
support a model in which bis-ANS binds to and stabilizes an open DnaK
conformational state that is spontaneously accessed by the protein
during steady state, thermally driven, conformational fluctuations
(34). By analogy, we hypothesize that GRP94 spontaneously interconverts
between two conformational states, inactive, or closed, and active or
open. In the inactive, or closed state, GRP94 is unable to stably
interact with substrate (poly)peptides, whereas in the open state a
pronounced molecular chaperone activity is displayed. Although such
conformational dynamics are readily apparent in the native protein and
can be rapidly elicited upon elevation of the temperature above
37 °C, such conformational changes, if regulated only by
temperature, would limit the activation of GRP94 chaperone function to
the heat shock state. However, the fact that such conformational
changes can be modulated by ligand binding to the N-terminal adenosine
nucleotide-binding domain suggests that ligands of the appropriate
structure can elicit a conformational change identical or similar to
that occurring during heat shock, even in the absence of thermal
stress. A ligand-mediated regulation of GRP94 conformation would allow
the activation of GRP94 chaperone activity under conditions other than
heat shock that disrupt protein folding, such as nutrient deprivation
and oxidative stress. In this and the accompanying manuscript (61), data are presented in support of an adenosine-based ligand, other than
ATP/ADP, that would regulate GRP94 function. At present, the existence
of such a native ligand(s) is entirely speculative.
A model summarizing the primary observations of this and the preceding
manuscript (61) is depicted in Fig. 8. In
this model, we postulate that the nucleotide-binding domains present in
each of the two identical subunits of GRP94 exist in either of two conformations. Operationally, the two conformations can be
distinguished by their ability to bind the adenosine derivative
N-ethylcarboxamidoadenosine. In this conformational state,
GRP94 displays low chaperone activity. During heat shock, or in the
presence of a suitable ligand (i.e. bis-ANS), GRP94
undergoes a tertiary conformational change that is accompanied by the
activation of chaperone activity. In this conformation, and at
sufficiently high GRP94 concentrations, GRP94 undergoes homotypic
oligomerization. In contrast, radicicol and geldanamycin, established
inhibitors of GRP94, are proposed to bind to the nucleotide-binding
domains of both subunits and thereby elicit a conformation in which
GRP94 chaperone activity is dramatically reduced or eliminated. In the
radicicol or geldanamycin bound state, GRP94 is unable to access an
active conformation, as would occur in response to heat shock.
In conclusion, we report the identification of a ligand elicited
conformational change in GRP94 that is accompanied by a marked activation of molecular chaperone and peptide binding activities. The
similarities between the conformations of GRP94 following heat shock
activation and bis-ANS binding support the conclusion that GRP94
conformation and activity can be regulated by ligand binding to the
N-terminal adenosine nucleotide-binding domain and that the
conformation of the protein in the bis-ANS liganded state is
physiologically relevant. Future studies will focus on the
relationships between GRP94 conformation and function, with an emphasis
on the identification of adenosine-based native ligands that stimulate
GRP94 molecular chaperone activity.
We gratefully acknowledge the assistance and
support of Dr. Terry Oas and Chris Henkels (Dept. of Biochemistry,
DUMC) for help with circular dichroism studies. We are indebted to Judy Phelps and the Howard Hughes Medical Institute, Duke University Medical
Center, for peptide sequencing studies.
*
This work was supported in part by National Institutes of
Health Grants DK53058 (to C. N.) and IF32CA8335501 (to
J. J. W.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed. Tel.: 919-684-8948;
Fax: 919-684-5481; E-mail: c.nicchitta@cellbio.duke.edu.
Published, JBC Papers in Press, May 17, 2000, DOI 10.1074/jbc.M001476200
2
M. Morrow, personal communication.
The abbreviations used are:
GRP94, glucose-regulated protein of 94 kDa;
bis-ANS, 1,1'-bis(4-anilino-5-napthalenesulfonic acid;
Hsp90, heat shock protein
of 90 kDa;
PAGE, polyacrylamide gel electrophoresis.
Ligand Interactions in the Adenosine Nucleotide-binding
Domain of the Hsp90 Chaperone, GRP94
II. LIGAND-MEDIATED ACTIVATION OF GRP94 MOLECULAR CHAPERONE AND
PEPTIDE BINDING ACTIVITY*
, and
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
385 = 16, 790 cm
1
M
1 in water). Citrate synthase (EC 4.1.3.7)
was purchased from Roche Molecular Biochemicals (Mannheim, Germany).
Radicicol was obtained from Dr. Len Neckers, National Cancer Institute,
Frederick, MD. Peptide VSV8 (RGYVYQGL) was synthesized by the
University of North Carolina at Chapel Hill Peptide Synthesis Facility
(Chapel Hill, NC). Na[125I] was purchased from Amersham
Pharmacia Biotech. All other reagents were obtained from Sigma unless
otherwise indicated. GRP94 was purified from porcine pancreas as
described previously (40). The concentration of GRP94 was determined by
absorbance at 280 nm (1A280 = 1.18 mg/ml).
-helical content of GRP94 was calculated
from the molar ellipticity at 222 nm (41).
-counting.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (40K):
[in a new window]
Fig. 1.
Prodan, ANS, and bis-ANS binding are
dependent on GRP94 structural state. Fluorescence emission
wavelength scans of 0.5 µM native or heat shocked
(hs) GRP94 were performed following exposure to:
A, 5 µM Prodan for 30 min; B, 5 µM 8-ANS for 30 min; C, 5 µM
bis-ANS was incubated with native GRP94 for 20 h or 1 min and with
heat-shocked GRP94 for 30 min. In A, B, and C
probe alone in buffer controls (no GRP94) are shown. D, time
course of bis-ANS binding to native GRP94. Values represent
bis-ANS/native GRP94 fluorescence relative to that occurring with
identical concentrations of heat-shocked GRP94 and bis-ANS. Experiments
were conducted at excitation wavelengths of 360 nm (Prodan), 372 nm
(8-ANS), and 393 nm (bis-ANS). All spectra were background
corrected.

View larger version (16K):
[in a new window]
Fig. 2.
Kinetic analysis of bis-ANS interactions with
heat-shocked GRP94. A, the concentration dependence of
bis-ANS binding to heat-shocked GRP94 was conducted under experimental
conditions of fixed bis-ANS concentration (50 nM) and
increasing GRP94 concentration, as indicated. B, Klotz plot
representation of bis-ANS/GRP94 binding data. Half-maximal binding
occurs at 110 nM GRP94. C, temperature
dependence of heat activation of GRP94 bis-ANS binding. 50 µg/ml
GRP94 was incubated for 15 h at the indicated temperatures, then
combined with 5 µM bis-ANS and the fluorescence emission
recorded. Excitation wavelength, 393 nm. Emission wavelength, 475 nm.

View larger version (95K):
[in a new window]
Fig. 3.
bis-ANS and heat shock increase GRP94
proteolysis sensitivity. GRP94 (5 µg, 5 µM) was
incubated with 50 µM bis-ANS for 1 h at 37 °C or
heat shocked for 15 min at 50 °C. Samples were then digested with
0.1% trypsin for 30 min at 37 °C and analyzed on 12.5% SDS-PAGE
gels. Lane 1, 5 µg of undigested GRP94; lane 2,
control native GRP94 incubated with trypsin; lane 3, bis-ANS
treated GRP94 digested with trypsin; lane 4, GRP94 heat
shocked then digested with trypsin. A digital image of a Coomassie
Blue-stained gel is depicted.

View larger version (78K):
[in a new window]
Fig. 4.
bis-ANS and heat shock induce GRP94
multimerization. GRP94 was heat shocked at 50 °C for 0-15 min
or incubated with 10-fold molar excess of bis-ANS for 1 h, and the
structural state of the protein analyzed on 5-18% native
blue-polyacrylamide gradient gels (5 µg of GRP94/lane). The
mobilities of GRP94 dimers, tetramers, hexamers, and octamers are
shown, with molecular mass standards indicated to the right
of the figure (thyroglobulin, 660 kDa; apoferritin, 440 kDa). A digital
image of a Coomassie Blue-stained gel is depicted.
-helix and
-sheet content, CD
spectroscopy can identify conformational changes occurring at the
secondary structure level. As shown in Fig.
5, the CD spectra for native,
heat-shocked, and bis-ANS-treated GRP94 were identical, indicating that
the conformational change occurring in the presence of bis-ANS is
primarily, if not entirely, limited to a tertiary structural
change.

View larger version (18K):
[in a new window]
Fig. 5.
Circular dichroism spectra of native,
heat-shocked, and bis-ANS-treated GRP94 are identical. Circular
dichrosim spectra of 1 µM GRP94 native (
), heat
shocked (
- - -), and treated 2 h with 10 µM
bis-ANS (

) are shown. Spectra were collected as described under
"Experimental Procedures."

View larger version (40K):
[in a new window]
Fig. 6.
Radicicol blocks heat shock and bis-ANS
structural transitions and bis-ANS binding. A, GRP94 (5 µM) was preincubated for 1 h at 37 °C with 0-500
µM radicicol and subsequently incubated for 1 h at
37 °C with 50 µM bis-ANS, trypsinized, and the trypsin
digestion pattern analyzed by SDS-PAGE. A digital image of a Coomassie
Blue-stained gel is shown. B, GRP94 (0.5 µM)
was preincubated with 0-10 µM radicicol for 1 h,
heat shocked, and subsequently incubated with 1 µM
bis-ANS. bis-ANS binding was determined by spectrofluorometry with
bis-ANS binding to native GRP94 in the absence of radicicol shown for
comparison. Excitation, 393 nm; emission, 410-600 nm.

View larger version (27K):
[in a new window]
Fig. 7.
bis-ANS and heat shock stimulate GRP94
chaperone and peptide binding activity. A, citrate
synthase enzyme was diluted to 0.15 µM into buffer
containing no GRP94, 1 µM native GRP94, heat-shocked
GRP94, or GRP94 which had been preincubated for 2 h with 10 µM bis-ANS, and citrate synthase aggregation at 43 °C
was monitored by light scattering at 500 nm in a thermostatted
spectrofluorometer. Bovine serum albumin protein and bis-ANS controls
did not affect citrate synthase aggregation. B, native,
heat-shocked, or bis-ANS-treated GRP94 were incubated with a 10-fold
molar excess of 125I-VSV8 peptide for 30 min at 37 °C.
Free peptide was removed by spin column chromatography and bound
radioactive peptide quantitated by
-counting.
-counting.
As shown in Fig. 7B, treatment of GRP94 with bis-ANS significantly enhanced the peptide binding activity of GRP94, yielding
approximately a 4-5-fold stimulation over native protein. Under
similar conditions, heat-shocked GRP94 displayed approximately a
10-fold stimulation of binding. From the data presented in Fig. 7,
A and B, it is apparent that bis-ANS elicits or
stabilizes a GRP94 conformation that displays markedly enhanced
molecular chaperone and peptide binding activities.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (29K):
[in a new window]
Fig. 8.
Model for the ligand-dependent
conformational regulation of GRP94 activity. The
nucleotide-binding domains of GRP94 are depicted as residing in either
of two conformations that differ in their capacity to bind the
adenosine derivative N-ethylcarboxamidoadenosine
(NECA). Following heat shock, or in the presence of
activating ligands, such as bis-ANS, GRP94 undergoes a tertiary
conformational change accompanied by a marked elevation of chaperone
and peptide binding activity. In this conformation, GRP94 can undergo,
in a concentration-dependent manner, homotypic
oligomerization. Inhibitors of GRP94 activity, such as geldanamycin and
radicicol are proposed to bind the nucleotide-binding domain of both
subunits and block the conformational acquisition of the active
state.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Recipient of an National Institutes of Health Medical Scientist
Training Program award.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Schaiff, W. T.,
Hruska, K. A., Jr.,
McCourt, D. W.,
Green, M.,
and Schwartz, B. D.
(1992)
J. Exp. Med.
176,
657-666
2.
Melnick, J.,
Aviel, S.,
and Argon, Y.
(1992)
J. Biol. Chem.
267,
21303-21306
3.
Melnick, J.,
Dul, J. L.,
and Argon, Y.
(1994)
Nature
370,
373-375
4.
Navarro, D.,
Qadri, I.,
and Pereira, L.
(1991)
Virology
184,
253-264
5.
Ferreira, L. R.,
Norris, K.,
Smith, T.,
Hebert, C.,
and Sauk, J. J.
(1996)
Connect. Tissue Res.
33,
265-273
6.
Chavany, C.,
Mimnaugh, E.,
Miller, P.,
Bitton, R.,
Nguyen, P.,
Trepel, J.,
Whitesell, L.,
Schnur, R.,
Moyer, J.,
and Neckers, L.
(1996)
J. Biol. Chem.
271,
4974-4977
7.
Kim, K. S.,
and Lee, A. S.
(1986)
Biochem. Biophys. Res. Commun.
140,
881-887
8.
Lee, A. S.
(1992)
Curr. Opin. Cell Biol.
4,
267-273
9.
Little, E.,
Ramakrishnan, M.,
Roy, B.,
Gazit, G.,
and Lee, A. S.
(1994)
Crit. Rev. Eukaryotic Gene Expr.
4,
1-18
10.
Srivastava, P. K.,
Udono, H.,
Blachere, N. E.,
and Li, Z.
(1994)
Immunogenetics
39,
93-98
11.
Arnold, D.,
Faath, S.,
Rammensee, H.,
and Schild, H.
(1995)
J. Exp. Med.
182,
885-889
12.
Nicchitta, C. V.
(1998)
Curr. Opin. Immunol.
10,
103-109
13.
Srivastava, P. K.,
Menoret, A.,
Basu, S.,
Binder, R. J.,
and McQuade, K. L.
(1998)
Immunity
8,
657-665
14.
Srivastava, P. K.,
DeLeo, A. B.,
and Old, L. J.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
3407-3411
15.
Suto, R.,
and Srivastava, P. K.
(1995)
Science
269,
1585-1588
16.
Nieland, T. J.,
Tan, M. C.,
Monne-van Muijen, M.,
Koning, F.,
Kruisbeek, A. M.,
and van Bleek, G. M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
6135-6139
17.
Breloer, M.,
Marti, T.,
Fleischer, B.,
and von Bonin, A.
(1998)
Eur. J. Immunol.
28,
1016-1021
18.
Nair, S.,
Wearsch, P. A.,
Mitchell, D. A.,
Wassenberg, J. J.,
Gilboa, E.,
and Nicchitta, C. V.
(1999)
J. Immunol.
162,
6426-6432
19.
Blachere, N. E.,
Li, Z.,
Chandawarkar, R. Y.,
Suto, R.,
Jaikaria, N. S.,
Basu, S.,
Udono, H.,
and Srivastava, P. K.
(1997)
J. Exp. Med.
186,
1315-1322
20.
Wearsch, P. A.,
and Nicchitta, C. V.
(1997)
J. Biol. Chem.
272,
5152-5156
21.
Wearsch, P. A.,
Voglino, L.,
and Nicchitta, C. V.
(1998)
Biochemistry
37,
5709-5719
22.
Sastry, S.,
and Linderoth, N.
(1999)
J. Biol. Chem.
274,
12023-12035
23.
Gerloff, D. L.,
Cohen, F. E.,
Korostensky, C.,
Turcotte, M.,
Gonnet, G. H.,
and Benner, S. A.
(1997)
Proteins
27,
450-458
24.
Prodromou, C.,
Roe, S. M.,
O'Brien, R.,
Ladbury, J. E.,
Piper, P. W.,
and Pearl, L. H.
(1997)
Cell
90,
65-75
25.
Obermann, W. M.,
Sondermann, H.,
Russo, A. A.,
Pavletich, N. P.,
and Hartl, F. U.
(1998)
J. Cell Biol.
143,
901-910
26.
Csermely, P.,
Schnaider, T.,
Soti, C.,
Prohaszka, Z.,
and Nardai, G.
(1998)
Pharmacol. Ther.
79,
129-168
27.
Sullivan, W.,
Stensgard, B.,
Caucutt, G.,
Bartha, B.,
McMahon, N.,
Alnemri, E. S.,
Litwack, G.,
and Toft, D.
(1997)
J. Biol. Chem.
272,
8007-8012
28.
Grenert, J. P.,
Johnson, B. D.,
and Toft, D. O.
(1999)
J. Biol. Chem.
274,
17525-17533
29.
Jakob, U.,
Lilie, H.,
Meyer, I.,
and Buchner, J.
(1995)
J. Biol. Chem.
270,
7288-7294
30.
Jakob, U.,
Scheibel, T.,
Bose, S.,
Reinstein, J.,
and Buchner, J.
(1996)
J. Biol. Chem.
271,
10035-10041
31.
Li, Z.,
and Srivastava, P. K.
(1993)
EMBO J.
12,
3143-3151
32.
Csermely, P.,
Miyata, Y.,
Schnaider, T.,
and Yahara, I.
(1995)
J. Biol. Chem.
270,
6381-6388
33.
Seale, J. W.,
Gorovits, B. M.,
Ybarra, J.,
and Horowitz, P. M.
(1996)
Biochemistry
35,
4079-4083
34.
Shi, L.,
Palleros, D. R.,
and Fink, A. L.
(1994)
Biochemistry
33,
7536-7546
35.
Rosen, C. G.,
and Weber, G.
(1969)
Biochemistry
8,
3915-3920
36.
Takashi, R.,
Tonomura, Y.,
and Morales, M. F.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
2334-2338
37.
Yoo, S. H.,
Albanesi, J. P.,
and Jameson, D. M.
(1990)
Biochim. Biophys. Acta
1040,
66-70
38.
Sharma, S. V.,
Agatsuma, T.,
and Nakano, H.
(1998)
Oncogene
16,
2639-2645
39.
Schulte, T. W.,
Akinaga, S.,
Murakata, T.,
Agatsuma, T.,
Sugimoto, S.,
Nakano, H.,
Lee, Y. S.,
Simen, B. B.,
Argon, Y.,
Felts, S.,
Toft, D. O.,
Neckers, L. M.,
and Sharma, S. V.
(1999)
Mol. Endocrinol.
13,
1435-1448
40.
Wearsch, P. A.,
and Nicchitta, C. V.
(1996)
Protein Expr. Purif.
7,
114-121
41.
Myers, J. S.,
and Jakoby, W. B.
(1975)
J. Biol. Chem.
250,
3785-3789
42.
Sharma, K. K.,
Kumar, G. S.,
Murphy, A. S.,
and Kester, K.
(1998)
J. Biol. Chem.
273,
15474-15478
43.
Seale, J. W.,
Brazil, B. T.,
and Horowitz, P. M.
(1998)
Methods Enzymol.
290,
318-323
44.
Schagger, H.,
Cramer, W. A.,
and von Jagow, G.
(1994)
Anal. Biochem.
217,
220-230
45.
Buchner, J.,
Grallert, H.,
and Jakob, U.
(1998)
Methods Enzymol.
290,
323-338
46.
Stebbins, C. E.,
Russo, A. A.,
Schneider, C.,
Rosen, N.,
Hartl, F. U.,
and Pavletich, N. P.
(1997)
Cell
89,
239-250
47.
Weber, G.,
and Farris, F. J.
(1979)
Biochemistry
18,
3075-3078
48.
Wearsch, P. A.,
and Nicchitta, C. V.
(1996)
Biochemistry
35,
16760-16769
49.
Nemoto, T.,
Matsusaka, T.,
Ota, M.,
Takagi, T.,
Collinge, D. B.,
and Walther-Larsen, H.
(1996)
J. Biochem. (Tokyo)
120,
249-256
50.
Roe, S. M.,
Prodromou, C.,
O'Brien, R.,
Ladbury, J. E.,
Piper, P. W.,
and Pearl, L. H.
(1999)
J. Med. Chem.
42,
260-266
51.
Scheibel, T.,
Weikl, T.,
and Buchner, J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
1495-1499
52.
Panaretou, B.,
Prodromou, C.,
Roe, S. M.,
O'Brien, R.,
Ladbury, J. E.,
Piper, P. W.,
and Pearl, L. H.
(1998)
EMBO J.
17,
4829-4836
53.
Csermely, P.,
Kajtar, J.,
Hollosi, M.,
Jalsovszky, G.,
Holly, S.,
Kahn, C. R.,
Gergely, P., Jr.,
Soti, C.,
Mihaly, K.,
and Somogyi, J.
(1993)
J. Biol. Chem.
268,
1901-1907
54.
Yonehara, M.,
Minami, Y.,
Kawata, Y.,
Nagai, J.,
and Yahara, I.
(1996)
J. Biol. Chem.
271,
2641-2645
55.
Chadli, A.,
Ladjimi, M. M.,
Baulieu, E. E.,
and Catelli, M. G.
(1999)
J. Biol. Chem.
274,
4133-4139
56.
Careri, G.,
Fasella, P.,
and Gratton, E.
(1975)
CRC Crit. Rev. Biochem.
3,
141-164
57.
Jaenicke, R.,
and Zavodszky, P.
(1990)
FEBS Lett.
268,
344-349
58.
Zavodszky, P.,
Kardos, J.,
Svingor,
and Petsko, G. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A
95,
7406-7411
59.
Klotz, I. M.,
and Hunston, D. L.
(1971)
Biochemistry
10,
3065-3069
60.
Cardamone, M.,
and Puri, N. K.
(1992)
Biochem. J.
282,
589-593
61.
Rosser, M. F. N.,
and Nicchitta, C. V.
(2000)
J. Biol. Chem
275,
22798-22805
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
V. M. Hermann, J. F. Cutfield, and M. J. Hubbard Biophysical Characterization of ERp29: EVIDENCE FOR A KEY STRUCTURAL ROLE OF CYSTEINE 125 J. Biol. Chem., April 8, 2005; 280(14): 13529 - 13537. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ostrowski, K. Klimek-Tomczak, L. S. Wyrwicz, M. Mikula, D. S. Schullery, and K. Bomsztyk Heterogeneous Nuclear Ribonucleoprotein K Enhances Insulin-induced Expression of Mitochondrial UCP2 Protein J. Biol. Chem., December 24, 2004; 279(52): 54599 - 54609. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Immormino, D. E. Dollins, P. L. Shaffer, K. L. Soldano, M. A. Walker, and D. T. Gewirth Ligand-induced Conformational Shift in the N-terminal Domain of GRP94, an Hsp90 Chaperone J. Biol. Chem., October 29, 2004; 279(44): 46162 - 46171. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gidalevitz, C. Biswas, H. Ding, D. Schneidman-Duhovny, H. J. Wolfson, F. Stevens, S. Radford, and Y. Argon Identification of the N-terminal Peptide Binding Site of Glucose-regulated Protein 94 J. Biol. Chem., April 16, 2004; 279(16): 16543 - 16552. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Soldano, A. Jivan, C. V. Nicchitta, and D. T. Gewirth Structure of the N-terminal Domain of GRP94: BASIS FOR LIGAND SPECIFICITY AND REGULATION J. Biol. Chem., November 28, 2003; 278(48): 48330 - 48338. [Abstract] [Full Text] [PDF] |
||||
![]() |
|